摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Methoxy-2-methyl-pentin-(4) | 28809-44-1

中文名称
——
中文别名
——
英文名称
2-Methoxy-2-methyl-pentin-(4)
英文别名
4-Methoxy-4-methyl-1-pentin;4-methoxy-4-methyl-pent-1-yne;4-Methoxy-4-methylpent-1-yne;4-methoxy-4-methylpent-1-yne
2-Methoxy-2-methyl-pentin-(4)化学式
CAS
28809-44-1
化学式
C7H12O
mdl
——
分子量
112.172
InChiKey
IXQRAPXONRFUSX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    118.1±23.0 °C(Predicted)
  • 密度:
    0.835±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    8
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors – Lead optimization – Part III
    作者:Claude Barberis、James Pribish、Elina Tserlin、Alexandre Gross、Mark Czekaj、Matthieu Barragué、Paul Erdman、Sachin Maniar、John Jiang、Luke Fire、Vinod Patel、Andrew Hebert、Mikhail Levit、Anlai Wang、Frank Sun、Shih-Min A. Huang
    DOI:10.1016/j.bmcl.2018.12.015
    日期:2019.2
    N-substituted azaindoles were discovered as promising pan-PIM inhibitors. Lead optimization is described en route toward the identification of a clinical candidate. Modulation of physico-chemical properties allowed to solve inherent hERG and permeability liabilities. Compound 17 showed tumor growth inhibition in a KG1 tumor-bearing mouse model.
    发现N-取代的吲哚吲哚是有希望的泛PIM抑制剂。在确定临床候选者的过程中描述了线索优化。理化性质的调节允许解决固有的hERG和渗透性负债。在具有KG1肿瘤的小鼠模型中,化合物17显示出肿瘤生长抑制作用。
  • COMPOSITION FOR USE IN A METHOD FOR LOWERING OF LDL-CHOLESTEROL IN PLASMA
    申请人:ezCol B.V.
    公开号:EP3897677A1
    公开(公告)日:2021-10-27
  • [EN] COMPOSITION FOR USE IN A METHOD FOR LOWERING OF LDL-CHOLESTEROL IN PLASMA<br/>[FR] COMPOSITION À UTILISER DANS UNE MÉTHODE VISANT À ABAISSER LE TAUX PLASMATIQUE DE CHOLESTÉROL LBD
    申请人:EZCOL B V
    公开号:WO2020130813A1
    公开(公告)日:2020-06-25
    The present invention relates to a (pharmaceutical) composition comprising geranyl-geranyl bacteriopheophytin a, phytyl derivative of bacteriopheophytin a, hydroxyspirilloxanthin, rhodovibrin, 3,4- rhodopin, chloroxanthin, rhodopin, spirilloxanthin, 3,4-spirilloxanthin, ubiquinol-10, ubiquinone-9, ubiquinone-10 and rhodoquinone-10, for use in a method for the lowering of LDL-cholesterol in subjects in need thereof. Furthermore, the invention relates to a foodstuff comprising a food supplement, wherein the food supplement has cholesterol-lowering properties and comprises compounds geranyl-geranyl bacteriopheophytin a, phytyl derivative of bacteriopheophytin a, hydroxyspirilloxanthin, rhodovibrin, 3,4- rhodopin, chloroxanthin, rhodopin, spirilloxanthin, 3,4-spirilloxanthin, ubiquinol-10, ubiquinone-9, ubiquinone-10 and rhodoquinone-10. For the pharmaceutical composition and the composition and the food supplement the proviso is that the (pharmaceutical) composition is not, and the compounds are not provided as, a petroleum ether extract of Rhodospirillum rubrum obtainable by extraction of Rhodospirillum rubrum cells with a mixture of petroleum ether with a boiling point of between 60°C and 80°C and methanol comprising sodium chloride, wherein the extract is obtained by extraction for between 10 minutes and 48 hours at between 8°C and 37°C, while mixing the cells with the mixture, and wherein the Rhodospirillum rubrum cells are extracted with the mixture in a volume ratio of between 10:1 and 1:10 of petroleum ether with a boiling point of between 60°C and 80°C and methanol comprising sodium chloride. Furthermore, the (pharmaceutical) composition and compounds are not comprising or provided as whole R.rubrum cells or as a membrane fraction of R.rubrum.
  • Carotenoids and related compounds. Part XVII. Synthesis of spirilloxanthin, “OH-spirilloxanthin,” and 3,4-dehydrorhodopin
    作者:D. F. Schneider、B. C. L. Weedon
    DOI:10.1039/j39670001686
    日期:——
    Spirilloxanthin, “OH-spirilloxanthin,” and 3,4-dehydrorhodopin have been synthesised. The structure proposed for α-bacterioruberin has been shown to require revision.
    合成了螺旋藻黄质,“ OH-螺旋黄质”和3,4-脱水视紫红质。对于α-细菌尿黄素提出的结构已显示需要修改。
  • Solvolyse des 1-Chlormethylen-2,2-dimethylcyclopropans.
    作者:Aurelia Ghenciulescu、Michael Hanack
    DOI:10.1016/s0040-4039(01)98351-0
    日期:1970.1
查看更多